US FDA Adds New Faces To Vaccines Adcomm For Pfizer/BioNTech COVID-19 Review

 
• By Derrick Gingery
  
FDA Advisory Committee Feature image
The 10 December Vaccines and Related Biological Products Advisory Committee meeting runs from 9 a.m. to 5:15 p.m. • Source: Pink Sheet illustration

More from US FDA Performance Tracker

More from Regulatory Trackers